Asia Pacific Qpcr Instruments Market Size & Outlook
- Clinical Diagnostics
- In Vitro Diagnostics
- QPCR Instruments Market Outlook
- In Vitro Diagnostics
Global Market
Related Markets
Ask a question about the qpcr instruments market
Asia Pacific qpcr instruments market highlights
- The Asia Pacific qpcr instruments market generated a revenue of USD 241.6 million in 2025.
- The market is expected to grow at a CAGR of 8% from 2026 to 2033.
- In terms of segment, quantstudio was the largest revenue generating type in 2025.
- QuantStudio is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2026 to 2033.
Asia Pacific data book summary
| Market revenue in 2025 | USD 241.6 million |
| Market revenue in 2033 | USD 443.1 million |
| Growth rate | 8% (CAGR from 2026 to 2033) |
| Largest segment | Quantstudio |
| Fastest growing segment | QuantStudio |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | QuantStudio, LightCycler, Cobas 4800/5800/6800/8800, GeneXpert, Rotor-Gene Q, BioFire FilmArray System, BMS Mic System, Cobas Z480, CFX |
| Key market players worldwide | Thermo Fisher Scientific Inc, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Danaher Corp, Qiagen NV, Agilent Technologies Inc, Abbott Laboratories, BioMerieux SA, Azure Biosystems, Bio Molecular Systems |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 20.3% of the global qpcr instruments market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 443.1 million by 2033.
Asia Pacific is estimated to exhibit a lucrative CAGR of 15.7% over the forecast period. It is expected to be the fastest-growing region over the forecast period. Cell and gene therapies are becoming a common treatment for cancer.
They form 50% of the total therapies approved for cancer globally, making it crucial in driving the demand for qPCR instruments. Hence, growing incidence of cancer in the region can propel the demand for biologics as well as cell & gene therapies.
Investments in vaccine manufacturing facilities are anticipated to further propel the market. For instance, Such initiatives are expected to position Asian markets as strong contenders for growing demand of qPCR.
No credit card required*
Publish Date: Mar 12, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
QPCR Instruments Market Scope
QPCR Instruments Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Azure Biosystems | View profile | 51-100 | Dublin, California, United States, North America | www.azurebiosystems.com/ |
| Bio Molecular Systems | View profile | 11-50 | Upper Coomera, Queensland, Australia, Oceania | biomolecularsystems.com |
Asia Pacific QPCR Instruments Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to QPCR Instruments Market Outlook will help companies and investors design strategic landscapes.
Quantstudio was the largest segment with a revenue share of 30.09% in 2025.
Horizon Databook has segmented the Asia Pacific qpcr instruments market based on quantstudio, lightcycler, cobas 4800/5800/6800/8800, genexpert, rotor-gene q, biofire filmarray system, bms mic system, cobas z480, cfx covering the revenue growth of each sub-segment from 2021 to 2033.
Asia Pacific is estimated to exhibit a lucrative CAGR of 15.7% over the forecast period. It is expected to be the fastest-growing region over the forecast period. Cell and gene therapies are becoming a common treatment for cancer.
They form 50% of the total therapies approved for cancer globally, making it crucial in driving the demand for qPCR instruments. Hence, growing incidence of cancer in the region can propel the demand for biologics as well as cell & gene therapies.
Investments in vaccine manufacturing facilities are anticipated to further propel the market. For instance, Such initiatives are expected to position Asian markets as strong contenders for growing demand of qPCR.
- Asia Pacific Qpcr Instruments Market Type Outlook (Revenue, USD Million , 2021-2033)
- 7500
- QuantStudio
- One Step/One Step Plus
- LightCycler
- cobas 4800/5800/6800/8800
- GeneXpert
- Rotor-Gene Q
- BioFire FilmArray System
- BMS Mic System
- cobas Z480
- CFX
- Others
Reasons to subscribe to QPCR Instruments Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of QPCR Instruments Market Outlook databook
- Our clientele includes a mix of QPCR Instruments Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific QPCR Instruments Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific QPCR Instruments Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Asia Pacific Qpcr Instruments Market, 2021-2033 (US$M)
Asia Pacific qpcr instruments market statistics, by type, 2021-2033 (US$M)
